新型抗高血糖药的研制-猫眼课题宝

新型抗高血糖药的研制

批准号：

7784494

负责人：

Zhaoping Li

金额：

$0.0万

依托单位：

VA GREATER LOS ANGELES HEALTHCARE SYSTEM

依托单位国家：

美国

项目类别：

财政年份：

2009

资助国家：

美国

项目状态：

已结题

起止时间：

2009-04-01 至 2012-09-30

来源：

https://reporter.nih.gov/project-details/7784494

关键词：

Adverse effects Adverse event Agreement Alzheimer&apos s Disease Amino Acids Animal Model Animals Asians Blood Blood Glucose Bone Density Brain Cardiovascular system Cause of Death Cell membrane Cells Centers for Disease Control and Prevention (U.S.)Chemistry Chronic Disease Clinical Clinical Trials Complex Copper Country Cytosol Defect Development Diabetes Mellitus Diabetes prevention Dipeptides Disease Dose Double-Blind Method Drops Environmental Risk Factor Enzyme Gene Enzymes European Event Expenditure FDA approved Fasting Future Gel Genes Genetic Genetic Polymorphism Glucagon Glucose Glucose Intolerance Glucose Transporter Glucose tolerance test Glycosylated hemoglobin A Health Healthcare Hematology Hepatic High Prevalence Hour Human Hyperglycemia Hypoglycemia Hypoglycemic Agents Impairment Injection of therapeutic agent Inpatients Insulin Insulin Receptor Insulin Resistance Insulinase Intake Intestines Kidney Lead Legal patent Leptin Literature Liver Liver Failure Marketing Mediating Medical Medical center Metformin Molecular Muscle Mutation National Health and Nutrition Examination Survey Nausea Non-Insulin-Dependent Diabetes Mellitus Obesity Oral Oral Administration Outcome Outcome Study Outpatients Patients Peptide Hydrolases Peptides Peripheral Pharmaceutical Preparations Pharmacy facility Phase Phase I Clinical Trials Pioglitazone Placebo Control Placebos Plasma Play Population Prevention Process Proteins Randomized Rattus Receptor Signaling Recruitment Activity Regimen Reporting Research Research Design Risk Role SLC2A1 gene Safety Services Severe Adverse Event Signal Transduction Stomach Sulfonylurea Compounds Symptoms Therapeutic Agents Thyroid Function Tests Tissues United States Urine Veterans Visit Vomiting Zinc Zinc deficiency absorption adiponectin analog base brain tissue capsule commercialization cost diabetic diabetic patient diet and exercise effective therapy experience fasting plasma glucose four-arm study functional disability glucogenesis glucose metabolism glucose output glucose uptake glycemic control histidylproline improved inhibitor/antagonist insulin sensitivity insulin signaling novel oral glucose tolerance primary outcome public health relevance receptor recycling rosiglitazone secondary outcome volunteer week trial

期刊论文(0)

专著(0)

科研奖励(0)

会议论文

Pomegranate Extract and Its Microbial Metabolite Urolithin A Suppress IBD through Modulation of the Gut Microbiome and T Cell Inflammatory Immune Responses

批准号：

10609810
项目类别：
资助金额：

$0.0万
财政年份：

2022
负责人：

Zhaoping Li
依托单位：

VA GREATER LOS ANGELES HEALTHCARE SYSTEM

Pomegranate Extract and Its Microbial Metabolite Urolithin A Suppress IBD through Modulation of the Gut Microbiome and T Cell Inflammatory Immune Responses

批准号：

10363573
项目类别：
资助金额：

$0.0万
财政年份：

2022
负责人：

Zhaoping Li
依托单位：

VA GREATER LOS ANGELES HEALTHCARE SYSTEM

BCAA Catabolic Defect in HF: Novel Mechanism and Therapeutic Target

批准号：

10063896
项目类别：
资助金额：

$39.0万
财政年份：

2018
负责人：

Zhaoping Li
依托单位：

UNIVERSITY OF CALIFORNIA LOS ANGELES

Development of A Novel Anti-Hyperglycemic Agent

批准号：

7687310
项目类别：
资助金额：

$0.0万
财政年份：

2009
负责人：

Zhaoping Li
依托单位：

VA GREATER LOS ANGELES HEALTHCARE SYSTEM

Development of A Novel Anti-Hyperglycemic Agent

批准号：

8196299
项目类别：
资助金额：

$0.0万
财政年份：

2009
负责人：

Zhaoping Li
依托单位：

VA GREATER LOS ANGELES HEALTHCARE SYSTEM

海外基金

Development of A Novel Anti-Hyperglycemic Agent

项目成果

Zhaoping Li的其他基金

相似基金

相关文献